Mycophenolate mofetil Active Not Recruiting Phase 2 Trials for Malignant Lymphomas / Multiple Myeloma and Plasma Cell Neoplasm / Graft Versus Host Disease (GVHD) / Leukemias / Precancerous/Nonmalignant Condition / Myelodysplastic/Myeloproliferative Diseases / Chronic Myeloproliferative Disorders / Myelodysplastic Syndromes (MDS) Treatment

Indications	Status	Purpose	Phase
DBCOND0046362 (Malignant Lymphomas) DBCOND0028463 (Multiple Myeloma and Plasma Cell Neoplasm) DBCOND0051557 (Graft Versus Host Disease (GVHD)) DBCOND0035632 (Leukemias) DBCOND0028484 (Precancerous/Nonmalignant Condition) DBCOND0028557 (Myelodysplastic/Myeloproliferative Diseases) DBCOND0028462 (Chronic Myeloproliferative Disorders) DBCOND0032544 (Myelodysplastic Syndromes (MDS))	Active Not Recruiting	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
https://clinicaltrials.gov/ct2/show/	Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders	Busulfan (DB01008) Cyclophosphamide (DB00531) Cyclosporine (DB00091) Etoposide (DB00773) Fludarabine (DB01073) Melphalan (DB01042) Methotrexate (DB00563) Mycophenolate mofetil (DB00688) Sirolimus (DB00877) Tacrolimus (DB00864)